Cargando…

Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report

INTRODUCTION: Autoimmune pancreatitis (AIP) is characterized by the involvement of autoimmune mechanisms and is classified as type 1, together with infiltration of IgG4-positive cells, and type 2 with poor serological abnormal findings. In clinical practice, AIP is often treated with steroid therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Yuichiro, Tatsumi, Fuminori, Kohara, Kenji, Shimoda, Masashi, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758037/
https://www.ncbi.nlm.nih.gov/pubmed/35029244
http://dx.doi.org/10.1097/MD.0000000000028609
_version_ 1784632815936077824
author Iwamoto, Yuichiro
Tatsumi, Fuminori
Kohara, Kenji
Shimoda, Masashi
Nakanishi, Shuhei
Mune, Tomoatsu
Kaku, Kohei
Kaneto, Hideaki
author_facet Iwamoto, Yuichiro
Tatsumi, Fuminori
Kohara, Kenji
Shimoda, Masashi
Nakanishi, Shuhei
Mune, Tomoatsu
Kaku, Kohei
Kaneto, Hideaki
author_sort Iwamoto, Yuichiro
collection PubMed
description INTRODUCTION: Autoimmune pancreatitis (AIP) is characterized by the involvement of autoimmune mechanisms and is classified as type 1, together with infiltration of IgG4-positive cells, and type 2 with poor serological abnormal findings. In clinical practice, AIP is often treated with steroid therapy. PATIENT CONCERNS: An 81-year-old Japanese woman had thirst and appetite loss in the previous 5 days; thus, she visited a local doctor. The patient had no abdominal or back pain. She had no history of diabetes mellitus, but at that time blood glucose level and HbA1c were as high as 633 mg/dL and 9.7%, respectively, and she was referred to our institution. DIAGNOSIS: Based on various clinical findings in this patient, we diagnosed her with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 AIP. INTERVENTIONS AND OUTCOMES: The patient completely recovered without steroid therapy and was withdrawn from insulin therapy. CONCLUSIONS: We should bear in mind the possibility of AIP when the sudden onset of hyperglycemia together with enlargement of the pancreas are observed in subjects without a history of diabetes mellitus.
format Online
Article
Text
id pubmed-8758037
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-87580372022-01-19 Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report Iwamoto, Yuichiro Tatsumi, Fuminori Kohara, Kenji Shimoda, Masashi Nakanishi, Shuhei Mune, Tomoatsu Kaku, Kohei Kaneto, Hideaki Medicine (Baltimore) 4300 INTRODUCTION: Autoimmune pancreatitis (AIP) is characterized by the involvement of autoimmune mechanisms and is classified as type 1, together with infiltration of IgG4-positive cells, and type 2 with poor serological abnormal findings. In clinical practice, AIP is often treated with steroid therapy. PATIENT CONCERNS: An 81-year-old Japanese woman had thirst and appetite loss in the previous 5 days; thus, she visited a local doctor. The patient had no abdominal or back pain. She had no history of diabetes mellitus, but at that time blood glucose level and HbA1c were as high as 633 mg/dL and 9.7%, respectively, and she was referred to our institution. DIAGNOSIS: Based on various clinical findings in this patient, we diagnosed her with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 AIP. INTERVENTIONS AND OUTCOMES: The patient completely recovered without steroid therapy and was withdrawn from insulin therapy. CONCLUSIONS: We should bear in mind the possibility of AIP when the sudden onset of hyperglycemia together with enlargement of the pancreas are observed in subjects without a history of diabetes mellitus. Lippincott Williams & Wilkins 2022-01-14 /pmc/articles/PMC8758037/ /pubmed/35029244 http://dx.doi.org/10.1097/MD.0000000000028609 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 4300
Iwamoto, Yuichiro
Tatsumi, Fuminori
Kohara, Kenji
Shimoda, Masashi
Nakanishi, Shuhei
Mune, Tomoatsu
Kaku, Kohei
Kaneto, Hideaki
Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
title Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
title_full Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
title_fullStr Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
title_full_unstemmed Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
title_short Dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: A case report
title_sort dramatic recovery without steroid therapy and withdrawal from insulin therapy in a subject with hyperglycemic and hyperosmolar syndrome and depletion of insulin secretory capacity induced by type 2 autoimmune pancreatitis: a case report
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758037/
https://www.ncbi.nlm.nih.gov/pubmed/35029244
http://dx.doi.org/10.1097/MD.0000000000028609
work_keys_str_mv AT iwamotoyuichiro dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT tatsumifuminori dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT koharakenji dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT shimodamasashi dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT nakanishishuhei dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT munetomoatsu dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT kakukohei dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport
AT kanetohideaki dramaticrecoverywithoutsteroidtherapyandwithdrawalfrominsulintherapyinasubjectwithhyperglycemicandhyperosmolarsyndromeanddepletionofinsulinsecretorycapacityinducedbytype2autoimmunepancreatitisacasereport